Terms: = Liver cancer AND ATRX, P46100, ZNF-HX, XNP, XH2, SHS, SFM1, RAD54, MRXHF1, MGC2094, ATR2, 546 AND Treatment
54 results:
1. NGS of brush cytology samples improves the detection of high-grade dysplasia and cholangiocarcinoma in patients with primary sclerosing cholangitis: A retrospective and prospective study.
Boyd S; Mustamäki T; Sjöblom N; Nordin A; Tenca A; Jokelainen K; Rantapero T; Liuksiala T; Lahtinen L; Kuopio T; Kytölä S; Mäkisalo H; Färkkilä M; Arola J
Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38551383
[TBL] [Abstract] [Full Text] [Related]
2. Multiregion WES of metastatic pancreatic neuroendocrine tumors revealed heterogeneity in genomic alterations, immune microenvironment and evolutionary patterns.
Jiang Y; Dong YH; Zhao SW; Liu DY; Zhang JY; Xu XY; Chen H; Chen H; Jin JB
Cell Commun Signal; 2024 Mar; 22(1):164. PubMed ID: 38448900
[TBL] [Abstract] [Full Text] [Related]
3. Factors associated with prolonged progression-free survival of patients treated with first-line afatinib for advanced epidermal growth factor receptor-mutated non-small cell lung cancer.
Chiu LC; Hsu PC; Wang CC; Ko HW; Kuo SC; Ju JS; Tung PH; Huang AC; Yang CT
Thorac Cancer; 2024 Mar; 15(7):529-537. PubMed ID: 38279515
[TBL] [Abstract] [Full Text] [Related]
4. The evolving phenotype of autoimmune hepatitis across the millennium: The 40-year experience of a referral centre in Italy.
Ferronato M; Lalanne C; Quarneti C; Panico ML; Guidi M; Lenzi M; Muratori L
Liver Int; 2024 Mar; 44(3):791-798. PubMed ID: 38230826
[TBL] [Abstract] [Full Text] [Related]
5. Combined hepatocellular cholangiocarcinoma in hepatectomy specimens: A clinicopathologic analysis.
Patil N; Sahai P; Rastogi A; Sharma N; Shasthry SM; Mukund A; Laroia ST; Kumar G; Pamecha V; Sarin SK
Indian J Pathol Microbiol; 2023; 66(4):744-750. PubMed ID: 38084526
[TBL] [Abstract] [Full Text] [Related]
6. Combined Hepatic Arterial Infusion Pump and Systemic Chemotherapy in the Modern Era for Chemotherapy-Naive Patients with Unresectable Colorectal liver Metastases.
Verheij FS; Kuhlmann KFD; Silliman DR; Soares KC; Kingham TP; Balachandran VP; Drebin JA; Wei AC; Jarnagin WR; Cercek A; Kok NFM; Kemeny NE; D'Angelica MI
Ann Surg Oncol; 2023 Dec; 30(13):7950-7959. PubMed ID: 37639032
[TBL] [Abstract] [Full Text] [Related]
7. Clinical features of cutaneous infantile hemangioma combined with asymptomatic infantile hepatic hemangioma and efficacy of propranolol treatment.
Li L; Yu L; Xu Z; Wei L; Zhang B; Han X; Sun Y; Ma L
J Cosmet Dermatol; 2023 Dec; 22(12):3369-3374. PubMed ID: 37313653
[TBL] [Abstract] [Full Text] [Related]
8. Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B.
Huang SC; Su TH; Tseng TC; Chen CL; Hsu SJ; Liao SH; Hong CM; Liu CH; Lan TY; Yang HC; Liu CJ; Chen PJ; Kao JH
Hepatol Int; 2023 Oct; 17(5):1139-1149. PubMed ID: 37247045
[TBL] [Abstract] [Full Text] [Related]
9. An elevated preoperative cholesterol-to-lymphocyte ratio predicts unfavourable outcomes in colorectal cancer liver metastasis patients receiving simultaneous resections: a retrospective study.
Deng Y; Chen Q; Chen J; Zhang Y; Zhao J; Bi X; Li Z; Zhang Y; Huang Z; Cai J; Zhao H
BMC Surg; 2023 May; 23(1):131. PubMed ID: 37194000
[TBL] [Abstract] [Full Text] [Related]
10. Primary and secondary angiosarcomas of the liver: a multi-institutional study of 32 cases.
Liao X; Lai J; Lin J; Zhang D
Hum Pathol; 2023 Jul; 137():10-17. PubMed ID: 37054784
[TBL] [Abstract] [Full Text] [Related]
11. A nomogram for preoperative prediction of microvascular invasion in ruptured hepatocellular carcinoma.
Xia F; Zhang Q; Ndhlovu E; Zheng J; Gao H; Xia G
Eur J Gastroenterol Hepatol; 2023 May; 35(5):591-599. PubMed ID: 36966771
[TBL] [Abstract] [Full Text] [Related]
12. Uterine Leiomyosarcoma Masquerading as a Malignant Perivascular Epithelioid Cell Tumor: A Diagnostic Challenge.
Natsume T; Yoshida H; Nishikawa T; Kikkawa N; Naka T; Kobayashi-Kato M; Tanase Y; Uno M; Ishikawa M; Kato T
Int J Surg Pathol; 2023 Aug; 31(5):778-784. PubMed ID: 36310451
[TBL] [Abstract] [Full Text] [Related]
13. Modelling the microelimination of chronic hepatitis C in the canton of Bern, Switzerland: Reaching the Swiss Hepatitis Strategy goals despite the impact of the COVID 19 pandemic.
Schorr O; Blach S; Thurnheer C; Ruis C; Dufour JF
PLoS One; 2022; 17(8):e0272518. PubMed ID: 35960770
[TBL] [Abstract] [Full Text] [Related]
14. sIL-2R- an Immuno-biomarker for Prediction of Metastases in Uveal Melanoma.
Barak V; Kalickman I; Pe'er J
Anticancer Res; 2022 Mar; 42(3):1447-1453. PubMed ID: 35220238
[TBL] [Abstract] [Full Text] [Related]
15. Health system costs and days in hospital for colorectal cancer patients in New South Wales, Australia.
Goldsbury DE; Feletto E; Weber MF; Haywood P; Pearce A; Lew JB; Worthington J; He E; Steinberg J; O'Connell DL; Canfell K
PLoS One; 2021; 16(11):e0260088. PubMed ID: 34843520
[TBL] [Abstract] [Full Text] [Related]
16. Clinical Safety and Efficacy of Locoregional Therapy Combined with Adoptive Transfer of Allogeneic γδ T Cells for Advanced Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Zhang T; Chen J; Niu L; Liu Y; Ye G; Jiang M; Qi Z
J Vasc Interv Radiol; 2022 Jan; 33(1):19-27.e3. PubMed ID: 34600129
[TBL] [Abstract] [Full Text] [Related]
17. Sunitinib and Evofosfamide (TH-302) in Systemic treatment-Naïve Patients with Grade 1/2 Metastatic Pancreatic Neuroendocrine Tumors: The GETNE-1408 Trial.
Grande E; Rodriguez-Antona C; López C; Alonso-Gordoa T; Benavent M; Capdevila J; Teulé A; Custodio A; Sevilla I; Hernando J; Gajate P; Molina-Cerrillo J; Díez JJ; Santos M; Lanillos J; García-Carbonero R
Oncologist; 2021 Nov; 26(11):941-949. PubMed ID: 34190375
[TBL] [Abstract] [Full Text] [Related]
18. Atezolizumab and bevacizumab combination compared with sorafenib as the first-line systemic treatment for patients with unresectable hepatocellular carcinoma: A cost-effectiveness analysis in China and the United states.
Wen F; Zheng H; Zhang P; Liao W; Zhou K; Li Q
Liver Int; 2021 May; 41(5):1097-1104. PubMed ID: 33556230
[TBL] [Abstract] [Full Text] [Related]
19. Long-term risk of primary liver cancers in entecavir versus tenofovir treatment for chronic hepatitis B.
Chang TS; Yang YH; Chen WM; Shen CH; Tung SY; Yen CW; Hsieh YY; Lee CP; Tsai ML; Hung CH; Lu SN
Sci Rep; 2021 Jan; 11(1):1365. PubMed ID: 33446835
[TBL] [Abstract] [Full Text] [Related]
20. Multi-Phase Cross-modal Learning for Noninvasive Gene Mutation Prediction in Hepatocellular Carcinoma.
Gu J; Zhao Z; Zeng Z; Wang Y; Qiu Z; Veeravalli B; Poh Goh BK; Kunnath Bonney G; Madhavan K; Ying CW; Kheng Choon L; Hua TC; Chow PKH
Annu Int Conf IEEE Eng Med Biol Soc; 2020 Jul; 2020():5814-5817. PubMed ID: 33019296
[TBL] [Abstract] [Full Text] [Related]
[Next]
